Literature DB >> 19783174

Infections in heart transplant recipients in Brazil: the challenge of Chagas' disease.

Henrique L Godoy1, Carla M Guerra, Ruy F Viegas, Rosiane Z Dinis, Joao N Branco, Vicente A Neto, Dirceu R Almeida.   

Abstract

BACKGROUND: Despite the high incidence of infections after heart transplantation, there is limited information about its epidemiology in patients from countries where Chagas' disease is endemic.
METHODS: We analyzed the occurrence of infections in 126 patients aged older than 18 years who underwent transplantation from 1986 through 2007 at a Brazilian University Hospital and who survived at least 48 hours.
RESULTS: Heart failure diagnoses before transplantation were idiopathic dilated cardiomyopathy (38.6%), Chagas' disease (34.9%), coronary artery disease (19.8%), and others (6.3%). The respiratory tract was the most common site of infections (40.9%), followed by surgical wound site (18.1%). Trypanosoma cruzi reactivations occurred in 38.8% of Chagas' disease patients: 47.0% had myocarditis, 23.5% had skin lesions, and 29.4% had both. New-onset ventricular dysfunction was observed in 47.0%, with complete response after specific treatment, and 41.0% were asymptomatic cases, diagnosed by routine endomyocardial biopsies. No patient died from such events. No differences in survival were found after 5 years of follow-up between recipients with and without Chagas' disease (p = 0.231).
CONCLUSIONS: In a heart transplant population from a developing country, infectious complications occurred at a high rate. Tropical illnesses were uncommon, except for the high rate of Chagas' disease reactivations. Despite that, the overall outcome of these patients was similar to that of recipients with other cardiomyopathies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19783174     DOI: 10.1016/j.healun.2009.08.006

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  9 in total

1.  New drugs for neglected infectious diseases: Chagas' disease.

Authors:  Fabiana S Machado; Herbert B Tanowitz; Mauro M Teixeira
Journal:  Br J Pharmacol       Date:  2010-05       Impact factor: 8.739

2.  Transplantation in the tropics: lessons on prevention and management of tropical infectious diseases.

Authors:  Ligia C Pierrotti; Camille N Kotton
Journal:  Curr Infect Dis Rep       Date:  2015-07       Impact factor: 3.725

3.  Emerging parasitic infections in transplantation.

Authors:  Roberta Lattes; Laura Linares; Marcelo Radisic
Journal:  Curr Infect Dis Rep       Date:  2012-12       Impact factor: 3.725

Review 4.  Diagnosis and Management of Chagas Cardiomyopathy in the United States.

Authors:  Lillian Benck; Evan Kransdorf; Jignesh Patel
Journal:  Curr Cardiol Rep       Date:  2018-10-11       Impact factor: 2.931

5.  Prognosis of chronic Chagas heart disease and other pending clinical challenges.

Authors:  Rosália Morais Torres; Dalmo Correia; Maria do Carmo Pereira Nunes; Walderez O Dutra; André Talvani; Andréa Silvestre Sousa; Fernanda de Souza Nogueira Sardinha Mendes; Maurício Ibrahim Scanavacca; Cristiano Pisani; Maria da Consolação Vieira Moreira; Dilma do Socorro Moraes de Souza; Wilson de Oliveira Junior; Silvia Marinho Martins; João Carlos Pinto Dias
Journal:  Mem Inst Oswaldo Cruz       Date:  2022-06-06       Impact factor: 2.747

6.  Long-term Survival Following Heart Transplantation for Chagas Versus Non-Chagas Cardiomyopathy: A Single-center Experience in Northeastern Brazil Over 2 Decades.

Authors:  Jefferson L Vieira; Maria G V Sobral; Francisco Y Macedo; Raquel S Florêncio; Germana P L Almeida; Glauber G Vasconcelos; Juliana R Fernandes; Laura L E Marinho; Daniel F M Trompieri; Tilak K R Pasala; Juan A C Mejia; João D Souza-Neto
Journal:  Transplant Direct       Date:  2022-06-24

7.  Reactivation of Chagas disease among heart transplant recipients in the United States, 2012-2016.

Authors:  Elizabeth B Gray; Ricardo M La Hoz; Jaime S Green; Holenarasipur R Vikram; Theresa Benedict; Hilda Rivera; Susan P Montgomery
Journal:  Transpl Infect Dis       Date:  2018-10-02       Impact factor: 2.228

Review 8.  Current and emerging therapeutic options for the treatment of chronic chagasic cardiomyopathy.

Authors:  Claudio A Muratore; Adrian Baranchuk
Journal:  Vasc Health Risk Manag       Date:  2010-08-09

9.  SARS-CoV-2 Infection and CMV Dissemination in Transplant Recipients as a Treatment for Chagas Cardiomyopathy: A Case Report.

Authors:  Sarah Cristina Gozzi-Silva; Gil Benard; Ricardo Wesley Alberca; Tatiana Mina Yendo; Franciane Mouradian Emidio Teixeira; Luana de Mendonça Oliveira; Danielle Rosa Beserra; Anna Julia Pietrobon; Emily Araujo de Oliveira; Anna Cláudia Calvielli Castelo Branco; Milena Mary de Souza Andrade; Iara Grigoletto Fernandes; Nátalli Zanete Pereira; Yasmim Álefe Leuzzi Ramos; Julia Cataldo Lima; Bruna Provenci; Sandrigo Mangini; Alberto José da Silva Duarte; Maria Notomi Sato
Journal:  Trop Med Infect Dis       Date:  2021-02-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.